Iron overload and hepatitis C virus (HCV) infection together can lead to chronic liver damage in thalassemia major (TM) patients.
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
Squadrito, GiovanniMembro del Collaboration Group
2016-01-01
Abstract
Iron overload and hepatitis C virus (HCV) infection together can lead to chronic liver damage in thalassemia major (TM) patients.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Dual therapy with peg-interferon and ribavirin in thalassemia major.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
450.76 kB
Formato
Adobe PDF
|
450.76 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.